What is the ROE (Return on Equity) of Virbac this year?
The ROE of Virbac this year is 0.13 undefined.
Virbac ROE 2024
Virbac ROE
0.13
Ticker
VIRP.PA
ISIN
FR0000031577
WKN
874929
In 2024, Virbac's return on equity (ROE) was 0.13, a -7.25% increase from the 0.15 ROE in the previous year.
Virbac Aktienanalyse
What does Virbac do?
Virbac SA is a French company specializing in animal medicines and care products. The company was founded in 1968 by Pierre Richard Dick, who studied veterinary medicine at the École nationale vétérinaire d'Alfort and gained experience as a veterinarian. Since its founding, Virbac SA has been headquartered near Carros, France and operates worldwide. The business model of Virbac SA is to offer a wide range of products to veterinarians and pet owners, aiming to ensure optimal health, care, and quality of life for their pets. This includes everything from vaccines, diagnostics, and medications to grooming products that veterinarians and pet owners need to ensure optimal pet healthcare. Virbac SA has five main business areas, namely livestock, pets, horses, hygiene products, and specialties. The livestock sector includes products such as feed additives and antiparasitics tailored to the specific needs of cattle, pigs, poultry, and fish. In the pets sector, Virbac SA offers products specifically tailored to dogs, cats, birds, and other pets. This includes both disease prevention and treatment products. In the horse sector, the company offers products for the maintenance, care, and health of horses. Another division of Virbac SA is hygiene products. The company offers a wide portfolio of products and solutions that support both veterinarians and pet owners in ensuring the health and care of animals. This ranges from infection control products to animal-specific shampoos and grooming items. The specialties sector, on the other hand, includes specialized products such as targeted diagnostics, therapeutics, and dietary supplements. The constant focus on research and development also leads to innovative product launches that consistently meet the highest quality standards. An example of this is the scientifically developed dental hygiene product line that improves both the oral health and breath quality of dogs and cats. For this, Virbac SA also receives awards from the Veterinary Center for Clinical Medicine in Munich. Through a systematic international expansion strategy, Virbac SA is now present in more than 100 countries. The company employs over 4,800 people worldwide and achieved a turnover of 954 million euros in 2019. Overall, Virbac SA stands for consistently high product quality and a strong customer orientation. With a combination of expertise and extensive scientific research and development, particularly in the field of animal health and care, the company is an important player in the global animal medicine manufacturing market. Virbac ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Virbac's Return on Equity (ROE)
Virbac's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Virbac's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Virbac's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Virbac’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Virbac Stock
How has the Return on Equity (ROE) of Virbac developed compared to the previous year?
The ROE of Virbac has increased by -7.25% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Virbac?
A high ROE indicates that Virbac generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Virbac?
A low ROE can indicate that Virbac is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Virbac affect the company?
A change in ROE (Return on Equity) of Virbac can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Virbac?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Virbac?
Some factors that can influence Virbac's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Virbac pay?
Over the past 12 months, Virbac paid a dividend of 1.32 EUR . This corresponds to a dividend yield of about 0.4 %. For the coming 12 months, Virbac is expected to pay a dividend of 1.5 EUR.
What is the dividend yield of Virbac?
The current dividend yield of Virbac is 0.4 %.
When does Virbac pay dividends?
Virbac pays a quarterly dividend. This is distributed in the months of July, July, July, July.
How secure is the dividend of Virbac?
Virbac paid dividends every year for the past 8 years.
What is the dividend of Virbac?
For the upcoming 12 months, dividends amounting to 1.5 EUR are expected. This corresponds to a dividend yield of 0.45 %.
In which sector is Virbac located?
Virbac is assigned to the 'Health' sector.
Wann musste ich die Aktien von Virbac kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Virbac from 6/27/2024 amounting to 1.32 EUR, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.
When did Virbac pay the last dividend?
The last dividend was paid out on 6/27/2024.
What was the dividend of Virbac in the year 2023?
In the year 2023, Virbac distributed 1.25 EUR as dividends.
In which currency does Virbac pay out the dividend?
The dividends of Virbac are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Virbac stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Virbac
Our stock analysis for Virbac Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Virbac Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
